Sonnet

Key Notes Sonnet BioTherapeutics, Inc.has decided to merge with Rorschach I LLC to become Hyperliquid Strategies. Hyperliquid Strategies will hold 12.6 million HYPE tokens and $305 million in cash, totaling $888 million in assets. The HYPE token has gained momentum as positive merger news fuels a broader crypto market rally. . Nasdaq-listed Sonnet BioTherapeutics, Inc. […]